XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Nov. 01, 2025
Nov. 02, 2024
Operating Activities:    
Net Loss $ (11) $ (25)
Adjustments to Reconcile Net Loss to Net Cash Used for Operating Activities:    
Depreciation and Amortization 185 192
Share-based Compensation Expense 41 45
Deferred Income Taxes 2 1
Gain on Sale of Assets 0 (6)
Changes in Assets and Liabilities:    
Accounts Receivable (29) (11)
Inventories (420) (305)
Accounts Payable, Accrued Expenses and Other 132 (55)
Income Taxes (20) (45)
Other Assets and Liabilities (54) (40)
Net Cash Used for Operating Activities (174) (249)
Investing Activities:    
Capital Expenditures (163) (150)
Proceeds from Sale of Assets 0 16
Other Investing Activities 0 1
Net Cash Used for Investing Activities (163) (133)
Financing Activities:    
Borrowings from Asset-based Revolving Credit Facility 545 460
Repayments of Borrowings from Asset-based Revolving Credit Facility (170) (165)
Tax Payments related to Share-based Awards (13) (9)
Payments of Long-term Debt (3) (3)
Proceeds from Stock Option Exercises 2 0
Payments for Contingent Consideration related to Adore Me Acquisition 0 (16)
Other Financing Activities (1) 5
Net Cash Provided by Financing Activities 360 272
Effects of Exchange Rate Changes on Cash and Cash Equivalents (1) 1
Net Increase (Decrease) in Cash and Cash Equivalents 22 (109)
Cash and Cash Equivalents, Beginning of Period 227 270
Cash and Cash Equivalents, End of Period $ 249 $ 161